|
COPYRIGHT 2005 International Medical News Group
SAN DIEGO -- Initiating treatment with pimecrolimus cream 1% during the early signs of atopic dermatitis in infants and children significantly reduced the incidence of flares, prolonged flare-free intervals, and reduced the need for a topical corticosteroid, Elaine Siegfried, M.D., reported during a poster session at the annual meeting of the Society for Pediatric Dermatology.
"This is a straightforward study that reflects what people experience in their practices," Dr. Siegfried told SKIN & ALLERGY NEWS. "When you use a steroid-sparing agent like topical pimecrolimus in combination with a steroid,...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
